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1. Introduction 
Active transport of solutes by cytoplasmic mem- 
brane vesicles from bacteria can be driven by electron 
transfer in respiratory chains, anaerobic electron 
transfer systems or by cyclic electron transfer 
systems (reviewed [ 1,2]). Electron transfer results in 
the generation of an electrochemical proton gradient 
across the membrane which is composed of an 
electrical gradient (A$) and a chemical proton 
gradient (ApH) according to the equation A&+ = 
A$-2.3 RT/F log ApH. The generation of a mem- 
brane potential and a pH gradient, induced by 
electron transfer, has been demonstrated in membrane 
vesicles from several bacteria [3,4]. 
The transmembrane pH gradient can be deter- 
mined from the accumulation of radioactively 
labeled weak acids or bases as measured by means of 
flow dialysis [5]. For the determination of the mem- 
brane potential several methods have been employed 
[3]. A very reliable method for small cells and mem- 
brane vesicles has been introduced [6]. These 
investigators demonstrated that lipophilic organic 
cations or anions distribute across the membrane in 
response to the membrane potential. The membrane 
potential can be calculated from the concentration 
gradient reached at steady state level of accumulation 
with the Nernst equation: 
A$ = RT/nF In qn/Cout 
in which n = valency of the ion, Gin = concentration 
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inside the membrane and Gout = the medium concen- 
tration of the lipophilic ion. 
Membrane potentials (inside negative) have been 
determined from the accumulation of several ipo- 
philic cations, i.e., dibenzyldimethylammonium 
(DDA) [7], tetraphenylphosphonium (TPP) [8] and 
triphenylmethylphosphonium (TPMP) [9]. A con- 
siderable disadvantage of all these cations is that they 
are not commercially available in radioactively labeled 
form or that complicated procedures are needed in 
order to synthesize these compounds in radioactive 
form. Here we describe the use of the lipophilic cation 
N-methyldeptropine (MDT) for A$ measurements in 
bacterial membrane vesicles. This compound can be 
synthesized in radioactive form by a very simple 
procedure. Two related compounds,N-methyltropine 
(MT) and N-methylatropine (NMA) were also 
investigated to get more information about the 
properties of an organic cation that determine its per- 
meability across the bacterial membrane and to act as 
a A$ probe. 
2. Materials 
2.1. Cellgrowth and preparation of membrane vesicles 
Escherichia coli ML 308-225 was grown under 
aerobic conditions at 37’C to late logarithmic phase 
on Davis-Mignoli medium supplemented with 0.1% 
yeast extract (Difco) and 1% sodium succinate as 
carbon and energy source. Membrane vesicles were 
isolated as in [2,10], suspended in 50 mM potassium 
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phosphate (pH 6.6) and stored in liquid nitrogen. For 
each experiment vesicle suspensians were used, which 
were frozen and thawed only once. 
2.2. Transport assays 
The vesicle uptake of radioactively labeled solutes 
was determined as in [2,9]. Assays were carried out 
at 20°C. The reaction mixture (100 ~1) contained 
0.1 mg ~neI~bral~e protein~m~, 50 mM potassium 
phosphate (pH 6.6) 10 mM magnesium sulphate and 
electron donor. For energization of the vesicles the 
non-physiological electron donor potassium ascorbate 
(IO mM) plus phenazine methosu~phate (PMS) 
(100 i.rM) was used. Before addition of the labeled 
soIt& the reaction mixture was allowed to equilibrate 
for 2 min. The uptake experiment was started by the 
addition of the labeled compound. The reaction was 
stopped by rapid dilution of the reaction mixture with 
2 ml 0.1 M LiCf and filtering over cehufose acetate 
filters (Ox&d m&Low membrane fifters N 25145 UP, 
pore size 0.45 ,um). The interrrai concentrations of 
solutes inside the membrane vesicles were calculated 
using 2.2pl/mgmembrane protein as the intravesicular 
volume [I I]. 
potentfal 
A suspension of membrane vesicles (1 .O m&l) in 
50 mM potassium phosphate (pH 6.6) was incubated 
at room temperature over 5 min with 4 PM vahno- 
mycin. The vesicles were washed once and resuspended 
in the same buffer to a protein concentration of 10, 
5 and 1 mg/ml respectively. At zero time these sus- 
pensions were diluted 100, 50 and 10 fold, respectively, 
into a reaction mixture, which contained 50 mM 
sodium phosphate (pH 6.6), 10 mM magnesium 
sulphate and the Labeled solute to a final volume of 
100 ~1. A reaction mixture, which contained 50 mM 
potassium phosphate instead of sodium phosphate was 
taken as control. 
2.4. Proiein det~~~~at~o~ 
Protein was assayed by the Lowry method rL2]. 
2.5. Synthesis of radioactively labeled N-methyl- 
deptropine and N-methylt?opitw 
Deptropine citrate was purchased from Gist- 
Brocades Pharmaca, Rijswijk (Z.H.). 
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“4C-Labelled 3a((10,1 I-dihydro-5H-dibenzo-[a,d]- 
~yclo~lepte~l-~-y~~x~)-S-methyltropalliurniodide 
(MDT) (spec. act. 1.21 ~Ci~~M) was synthesized from 
deptropine citrate and [‘4C]methyliodide by the 
central laboratory of TNO, Delft, by combining 
equimolar quantities of deptropine citrate and 
[ ~~C]r~~ethyliodide issolved in acetone. The mixture 
was incubated at room temperature for 3 days. The 
acetone was distilled off and the residue dissolved in 
water. Purity control was performed by thin-layer 
chromatography (TLC) and scanning. Radiochemical 
purity was >98%. 
~-~14C]methyltro~aniumiodide {MT) (spec. act. 
f .21 ~Ci~~M) was synthesized by hydrolysis of 
[ r4C]MDT with 10 mM HCI at pH 2. After centri- 
fugation the supernatant contained only MT, a pre- 
cipitate was formed by the cyclohepten part. The 
supernatant was neutralized to pH 6.6 with KOH. 
Purity control was performed by TLC and scanning. 
~adioche~n~~~ purity was >98%. Aqueous solutions 
of MT and MDT are very stable, but NMA easily 
decomposes [141. 
2.6. Materials 
Trit~um-labeled TPP (spec. act. 50 #Z/PM) was 
kindly donated by Dr H. R. Kaback, Roche Institute 
of Molecular Biology, Nutley, 07110 NJ. N-[14Cf- 
methylatropine (NMA) (spec. act. 6.98 ,uCi/ 
,uM) was a generous gift of Dr A. M. Soeterboek. All 
other chemicals used were reagent grade and obtained 
from commercial sources. 
3. Results 
3.1, Physicochemical properties 
MDT and NMA are synthetic analogues of atropine 
and belong to the pharmacologic class of” anti&o- 
linergics ]13,1S--171. MT is the product ofhydrolysis 
of both MDT and NMA. The structures of MT, MDT 
and NMA are given in fig.1. All three compounds con- 
tain the quaternary tropine part; only the chemical 
structure of the substituted alcohol group of the 
tropine moiety varies. The partitiun of MT, MDT and 
NMA between n-oetanol and various aqueous phases 
has been determined as an indication of their lipo- 
philicity (table 1). The partition behaviour of these 
structurally related compounds differs considerably, 
Only MDT dissolves well in octand, indicating that 
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Fig.1. Structure of MT, MDT and NMA. The asterisk shows the position of the label. 
Table 1 
Partition of MT, MDT and NMA between octanol and various 
aqueous phases, determined by the rotating flask method 
MDT is more lipophilic than MT or NMA. This obser- 
vation shows that the sidegroup of the tropine part 
determines to a larae extent the solubilitv in octanol. 
Compound % dissolved in octanol (pH 7.4) It remains to be established whether ion-pair forma- 
tion of the particular cations with anions in the media 
Krebs-NaOH Krebs-bicarbonate also effects this partition behaviour. 
MT 
MDT 
NMA 
< 0.1 
24.5 
0.8 
< 1.0 
88.5 
1.6 
< 1.0 
90.8 
1.6 
3.2. Uptake of MDT and TPP by membrane vesicles 
Uptake of MDT and TPP by membrane vesicles of 
Escherichia coli ML 308-225 was observed in the 
presence of ascorbate-PMS (fig.2). Uptake of MDT 
8 
I 
t 
TPP 
0 1 2 3 4 50 1 2 3 4 5 
TIME fMIN1 
Fig.2. Time-course of MDT and TPP uptake. (0) In the presence of 10 mM ascorbate and 100 nM PMS. (X) No electrondonor 
added. The final concentrations of MDT and TPP were 100 PM. 
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occurred somewhat slower than that of TPP, but the 
finat steady state was reached within 5 min. Steady 
state levels were reached, which were several fold 
higher than those observed under non-energized con- 
ditions. Assuming that like TPP, MDT pas$vely 
equilibrates according to the A$, the membrane 
potentials’(~nside negative) calculated from the dif- 
ference in steady state Ievefs of accun~u~ation u der 
energized and non-energized conditions are 
-68 + 2.5 mV (rr = 7) for MDT and -72 + 2.5 mV 
(n = 2) for TPP. These values are in good agreement 
with the membrane potential observed [l S] under 
identical conditions. The MDT concentration did not 
influence this value up to 1 SO PM. However at 
200 FM a significant lowering of the membrane 
potential was found. No accumulation of the related 
compounds MT and NMA could be observed under 
non-energized nor under energized conditions (results 
not shown). It is of interest that rapid uptake of MT 
and MDT was found in animal cells [ 13 ,f 91: but the 
mechanism of transport remained unclear. 
3.3. Effect of ionophores 
The uptake of MDT and TPP in the presence of 
ascorbate-PMS was inhibited to the non-energized 
level in the presence of the potassium ionophore 
vaii~om~c~n (t&3), which is known to diminish the 
A$ by producing a potassium flux, A similar ~n~bit~on 
was observed in the presence of the uncoupler FCCP 
(fig.4) which acts as a proton ionophore and abolishes 
both ApH and A$. On the other hand, nigericin, a 
proton-potassium antiporter, has hardly any effect 
on the ascorbate-PMS energized uptake of MDT 
(fig.4). In the presence of nigericin the ApH is 
dissipated by an electroneutral exchange of H’ 
against K’. A membrane potential of -70.5 mV could 
be calculated under these conditions. 
potassium diffusion poteMal 
When MDT is accumulated in response to a mem- 
brane potential (inside negative), it should be possible 
to drive MDT uptake by an artificially generated 
membrane potential. Such a membrane potential is 
induced by a v~inomycin mediated potassium efflux. 
Figure 5 shows that indeed accumuiation of MDT can 
be driven by such a diffusion potential and that the 
maximum level of uptake increases with increasing 
magnitude of this potential. Similar results have 
been obtained with TPMP 191. The transient nature 
TPP 
0 1 2 3 4 60 1 2 3 4 6 
TIME IMIN) 
Fig.3. Effect ofvalinomycin on MDT and TPP uptake. (0) In the presence of 10 mM ascorbate and 100 Ctrn PMS. (X) No 
electrondonor added. The final concentration of MDT was 100 PM; of TPP 40 PM. Valinomycin was added to a final coneen- 
tration of 4 PM. 
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1 2 3 4 5 
TME (MIN) 
FigA. Effect of nigericin and FCCP on MDT uptake. (0) In 
the presence of 10 mM ascorbate, 100 PM PMS and 2 rM 
nigericin. (0) In the presence of 10 mM ascorbate, 100 tiM 
PMS and 2 PM FCCP. (X) No electrondonor added. The final 
concentration of MDT was 100 PM. 
of the uptake is most likely due to secondary ion 
movements. 
4. Discussion and conclusions 
The results demonstrate hat MDT, just like TPP, 
equilibrates across the bacterial vesicle membrane in 
response to a A$. MDT is accumulated to the same 
extent as TPP; accumulation isinhibited under con- 
ditions of decreased membrane potentia1 (in the 
presence of va~inomycin or FCCP) but not under 
conditions of decreased pH gradient (in the presence 
of nigericin), Moreover MDT is accumulated when a 
valinomycin-potassium diffusion potential is imposed 
across the vesicle membrane, The kinetics of uptake 
of MDT are in the same order as those of TPP. It is 
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Fig.5. Uptake of MDT in response to av~omycin-pota~ium 
diffusion potential. The vesicle suspension was diluted 
10x (0), 50x (0) and 100X (0) (control: X). The final con- 
centration of MDT was 100 MM. 
concluded that MDT distributes according to the 
membrane potential and that the drug is a useful 
probe for A$ measurements. It has the advantage that 
it can be easily synthesized from commercially 
available precursors. 
The low partition coefficient of MT and NMA in 
contrast to the high partition coefficient of MDT and 
the observation that MT and NMAare not accumulated 
by membrane vesicIesofEscherichiacoliML308-225, 
indicate that the sidegroup of the tropine part 
determines to a large extent the lipophilic properties 
of MDT. 
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